Skip to main content
. 2021 Feb 12;11:620374. doi: 10.3389/fimmu.2020.620374

Figure 1.

Figure 1

Generic recipe of classical monocyte-derived dendritic cells (DCs). Monocytes are obtained from the patient’s peripheral blood and cultured with IL-4 and GM-CSF to generate immature DCs. These cells are subsequently exposed to activating factors for maturation and loaded with tumor-associated antigens (TAAs). The antigen-loaded DCs are then cryopreserved and injected back into the patient. Different sources of TAAs can be used and include cancer cell line lysate, whole tumor lysate, tumor-derived peptides, (synthetic) protein antigen(s), mRNA(s) encoding selected tumor antigen(s), autologous whole-tumor-derived mRNA, or antigens packaged within viral vectors.